Role of novel proteins in diabetes risk
24 November 2021
The purpose of the study is to investigate the involvement of novel proteins implicated with diabetes risk progression. This research will help to advance our understanding of the defects associated with insulin resistance, a pre-diabetic state. Research in the lead investigators laboratories has demonstrated that these novel proteins may contribute to the development of type 2 diabetes. However, the mechanism by which these proteins are regulated is not fully understood.
Keywords
Ethical approval
Ethics approval during the COVID-19 pandemic was given on the basis that researchers follow all University guidelines and procedures in respect of research during this time. This project has been granted an exception to the University requirement to conduct research with participants remotely during the COVID-19 pandemic.
About the researcher
Diana Motei, a Ph.D. research student is working alongside Dr. Richard Mackenzie as principal investigators of the presented study held at the University of Roehampton.
Dr. Richard Mackenzie is internationally recognised for his research into human metabolism, obesity, type 2 diabetes, and elite athletic performance. He leads a research team that investigates the role muscle plays in maintaining our health and how lifestyle, nutrition, and exercise influence this. Dr. Mackenzie has over 15 years of experience in helping people with a range of health-related issues, including obesity, to help them better understand their metabolism to encourage weight loss. In addition, Dr. Mackenzie also works with aspiring athletes to help them achieve their training goals, target performance weaknesses as well as improve over aerobic and metabolic performance.
